Clinical trial
Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty
NCT00289601 · Brigham and Women's Hospital, Other · Terminated
Key facts
| NCT number | NCT00289601 |
|---|---|
| Title | Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty |
| Official title | Research Evaluation to Study Individuals Who Show Thromboxane Or P2Y12 Receptor Resistance |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Schering-Plough Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Angioplasty |
| Intervention type | Drug |
| Interventions | eptifibatide |
| Enrollment | 1,200 |
| Start date | Mar 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | Feb 10, 2006 |
| Last update posted | Jul 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: